Charting a course in metastatic castration-sensitive prostate cancer

被引：0
|
作者：
Ravi A. Madan
William L. Dahut
机构：
[1] Genitourinary Malignancies Branch,
[2] National Cancer Institute Center for Cancer Research,undefined
[3] National Institute of Health,undefined
来源：
Nature Reviews Urology | 2015年 / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent studies in metastatic castration-sensitive prostate cancer have highlighted the potential benefits of giving systemic treatment with androgen deprivation earlier. Although such an approach might significantly improve survival, data showing such an effect may not be available for many years after trial initiation, and intermediate end points might facilitate future studies.
引用
收藏
页码：368 / 369
页数：1
相关论文
共 50 条
  • [1] Charting a course in metastatic castration-sensitive prostate cancer
    Madan, Ravi A.
    Dahut, William L.
    [J]. NATURE REVIEWS UROLOGY, 2015, 12 (07) : 368 - 369
  • [2] Chemotherapy for metastatic castration-sensitive prostate cancer
    Parimi, Sunil
    Chi, Kim N.
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2016, 23 (09) : 726 - 733
  • [3] Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Chi, Kim N.
    Agarwal, Neeraj
    Bjartell, Anders
    Chung, Byung Ha
    Pereira de Santana Gomes, Andrea J.
    Given, Robert
    Juarez Soto, Alvaro
    Merseburger, Axel S.
    Ozguroglu, Mustafa
    Uemura, Hirotsugu
    Ye, Dingwei
    Deprince, Kris
    Naini, Vahid
    Li, Jinhui
    Cheng, Shinta
    Yu, Margaret K.
    Zhang, Ke
    Larsen, Julie S.
    McCarthy, Sharon
    Chowdhury, Simon
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (01): : 13 - 24
  • [4] Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or ...
    Barata, Pedro C.
    Sartor, A. Oliver
    [J]. CANCER, 2019, 125 (11) : 1777 - 1788
  • [5] Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer
    Sheridan M. Hoy
    [J]. Drugs, 2020, 80 : 1579 - 1585
  • [6] The evolving options in metastatic castration-sensitive prostate cancer
    Hamilou, Zineb
    [J]. CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2020, 14 (03) : 270 - 275
  • [7] Use of Apalutamide for metastatic, castration-sensitive Prostate Cancer
    Thomas, C.
    [J]. UROLOGE, 2019, 58 (12): : 1496 - 1497
  • [8] Apalutamide for the treatment of metastatic castration-sensitive prostate cancer
    Dror, Corinne Maurice
    Chi, Kim Nguyen
    [J]. FUTURE ONCOLOGY, 2020, 16 (35) : 2905 - 2916
  • [9] Treatment Options in Metastatic Castration-Sensitive Prostate Cancer
    Choudhury, Atish D.
    [J]. ONCOLOGY-NEW YORK, 2022, 36 (03): : 184 - 185
  • [10] Re: Apalutamide for Metastatic, Castration-Sensitive Prostate Cancer
    Taneja, Samir S.
    [J]. JOURNAL OF UROLOGY, 2019, 202 (04): : 661 - 661
12345